Apogee Therapeutics, Inc. Common Stock (APGE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for APGE. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 5,507,032 | $731M | INCREASED |
| State Street | 2,297,743 | $305M | INCREASED |
| Remedium Capital Partners | 586,691 | $78M | INCREASED |
| Citigroup | 289,464 | $38M | INCREASED |
| BNY Mellon | 152,815 | $20M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Carl Dambkowski (Chief Medical Officer) | EXERCISE | 4,125 | $94K | 2026-08-05 |
| Carl Dambkowski (Chief Medical Officer) | SELL | 5,500 | $738K | 2026-08-05 |
| Jane Henderson (Chief Financial Officer) | GIFT | 15,000 | 2026-07-24 | |
| Carl Dambkowski (Chief Medical Officer) | GIFT | 8,000 | 2026-07-14 | |
| Michael Thomas Henderson (Chief Executive Officer) | GIFT | 75,046 | 2026-07-08 |
Full institutional holdings, insider history, and congressional trades for Apogee Therapeutics, Inc. Common Stock on SentiSense.